SLC30A6P1

Across TCGA pan-cancer cohorts, SLC30A6P1 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated SLC30A6P1 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher SLC30A6P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SLC30A6P1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and CESC show a favorable association.

UCS, ACC, and BRCA are the cancer types where SLC30A6P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	II,III,IV	0.077	0.630	<.001	72	view →
ACC	OS	Tertile	All	0.261	0.717	<.001	71	view →
BRCA	OS	Tertile	II,III,IV	0.889	0.961	<.001	60	view →
THCA	DFS	Tertile	II,III,IV	0.215	0.762	<.001	54	view →
HNSC	DFS	Tertile	All	0.778	0.589	.016	45	view →
SKCM	DFS	Tertile	III,IV	0.366	0.634	.002	39	view →
CESC	DFS	Tertile	All	1.000	0.516	.023	18	view →
TGCT	OS	Tertile	II,III,IV	0.802	1.000	.040	18	view →
DLBC	OS	Tertile	All	0.053	0.936	<.001	18	view →
MESO	DFS	Tertile	III,IV	0.203	0.427	.034	9	view →
STAD	OS	Tertile	II,III,IV	0.566	0.752	.042	6	view →
KICH	OS	Tertile	All	0.646	0.907	.042	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

SLC30A6P1–UCS (OS)

Open the UCS breakdown →